Publications in DiVA – Taija Mäkinen
-
APOLD1 loss causes endothelial dysfunction involving cell junctions, cytoskeletal architecture, and Weibel-Palade bodies, while disrupting hemostasis
Part of Haematologica, p. 772-784, 2023.
DOI for APOLD1 loss causes endothelial dysfunction involving cell junctions, cytoskeletal architecture, and Weibel-Palade bodies, while disrupting hemostasis Download full text (pdf) of APOLD1 loss causes endothelial dysfunction involving cell junctions, cytoskeletal architecture, and Weibel-Palade bodies, while disrupting hemostasis
-
Immune-interacting lymphatic endothelial subtype at capillary terminals drives lymphatic malformation
Part of Journal of Experimental Medicine, 2023.
DOI for Immune-interacting lymphatic endothelial subtype at capillary terminals drives lymphatic malformation Download full text (pdf) of Immune-interacting lymphatic endothelial subtype at capillary terminals drives lymphatic malformation
-
Mapping the lymphatic system across body scales and expertise domains: A report from the 2021 National Heart, Lung, and Blood Institute workshop at the Boston Lymphatic Symposium
Part of Frontiers in Physiology, 2023.
DOI for Mapping the lymphatic system across body scales and expertise domains: A report from the 2021 National Heart, Lung, and Blood Institute workshop at the Boston Lymphatic Symposium Download full text (pdf) of Mapping the lymphatic system across body scales and expertise domains: A report from the 2021 National Heart, Lung, and Blood Institute workshop at the Boston Lymphatic Symposium
-
Angiogenesis depends upon EPHB4-mediated export of collagen IV from vascular endothelial cells
Part of JCI Insight, 2022.
DOI for Angiogenesis depends upon EPHB4-mediated export of collagen IV from vascular endothelial cells Download full text (pdf) of Angiogenesis depends upon EPHB4-mediated export of collagen IV from vascular endothelial cells
-
Cellular Origin of Sporadic CCMs
Part of New England Journal of Medicine, p. 1291-1291, 2022.
-
Lymphangiogenesis requires Ang2/Tie/PI3K signaling for VEGFR3 cell-surface expression
Part of Journal of Clinical Investigation, 2022.
DOI for Lymphangiogenesis requires Ang2/Tie/PI3K signaling for VEGFR3 cell-surface expression Download full text (pdf) of Lymphangiogenesis requires Ang2/Tie/PI3K signaling for VEGFR3 cell-surface expression
-
The SARS-CoV-2 receptor ACE2 is expressed in mouse pericytes but not endothelial cells: Implications for COVID-19 vascular research
Part of Stem Cell Reports, p. 1089-1104, 2022.
-
An inducible Cldn11-CreERT2 mouse line for selective targeting of lymphatic valves
Part of Genesis, 2021.
DOI for An inducible Cldn11-CreERT2 mouse line for selective targeting of lymphatic valves Download full text (pdf) of An inducible Cldn11-CreERT2 mouse line for selective targeting of lymphatic valves
-
Homeostatic maintenance of the lymphatic vasculature
Part of Trends in Molecular Medicine, p. 955-970, 2021.
DOI for Homeostatic maintenance of the lymphatic vasculature Download full text (pdf) of Homeostatic maintenance of the lymphatic vasculature
-
Lymphatic Malformations: Genetics, Mechanisms and Therapeutic Strategies
Part of Circulation Research, p. 136-154, 2021.
DOI for Lymphatic Malformations: Genetics, Mechanisms and Therapeutic Strategies
-
Transcription factor FOXP2 is a flow-induced regulator of collecting lymphatic vessels
Part of EMBO Journal, 2021.
DOI for Transcription factor FOXP2 is a flow-induced regulator of collecting lymphatic vessels Download full text (pdf) of Transcription factor FOXP2 is a flow-induced regulator of collecting lymphatic vessels
-
Upregulation of VCAM-1 in lymphatic collectors supports dendritic cell entry and rapid migration to lymph nodes in inflammation
Part of Journal of Experimental Medicine, 2021.
-
Blockade of VEGF-C signaling inhibits lymphatic malformations driven by oncogenic PIK3CA mutation
Part of Nature Communications, 2020.
DOI for Blockade of VEGF-C signaling inhibits lymphatic malformations driven by oncogenic PIK3CA mutation Download full text (pdf) of Blockade of VEGF-C signaling inhibits lymphatic malformations driven by oncogenic PIK3CA mutation
-
EphrinB2-EphB4 signalling provides Rho-mediated homeostatic control of lymphatic endothelial cell junction integrity
Part of eLIFE, 2020.
DOI for EphrinB2-EphB4 signalling provides Rho-mediated homeostatic control of lymphatic endothelial cell junction integrity Download full text (pdf) of EphrinB2-EphB4 signalling provides Rho-mediated homeostatic control of lymphatic endothelial cell junction integrity
-
Tamoxifen-independent recombination of reporter genes limits lineage tracing and mosaic analysis using CreER(T2) lines
Part of Transgenic research, p. 53-68, 2020.
DOI for Tamoxifen-independent recombination of reporter genes limits lineage tracing and mosaic analysis using CreER(T2) lines Download full text (pdf) of Tamoxifen-independent recombination of reporter genes limits lineage tracing and mosaic analysis using CreER(T2) lines
-
Neurobiology: A Drain At The Base Of The Brain
Part of Nature, p. 34-35, 2019.
-
YAP and TAZ Negatively Regulate Prox1 During Developmental and Pathologic Lymphangiogenesis
Part of Circulation Research, p. 225-242, 2019.
DOI for YAP and TAZ Negatively Regulate Prox1 During Developmental and Pathologic Lymphangiogenesis
-
Genetic Lineage Tracing of Lymphatic Endothelial Cells in Mice.
Part of Methods in Molecular Biology, p. 37-53, 2018.
DOI for Genetic Lineage Tracing of Lymphatic Endothelial Cells in Mice.
-
Heterogeneity in VEGFR3 levels drives lymphatic vessel hyperplasia through cell-autonomous and non-cell-autonomous mechanisms
Part of Nature Communications, 2018.
DOI for Heterogeneity in VEGFR3 levels drives lymphatic vessel hyperplasia through cell-autonomous and non-cell-autonomous mechanisms Download full text (pdf) of Heterogeneity in VEGFR3 levels drives lymphatic vessel hyperplasia through cell-autonomous and non-cell-autonomous mechanisms
-
Matrix stiffness controls lymphatic vessel formation through regulation of a GATA2-dependent transcriptional program
Part of Nature Communications, 2018.
DOI for Matrix stiffness controls lymphatic vessel formation through regulation of a GATA2-dependent transcriptional program Download full text (pdf) of Matrix stiffness controls lymphatic vessel formation through regulation of a GATA2-dependent transcriptional program
-
Dachsousl-Fat4 Signaling Controls Endothelial Cell Polarization During Lymphatic Valve Morphogenesis-Brief Report
Part of Arteriosclerosis, Thrombosis and Vascular Biology, p. 1732-1735, 2017.
-
Human Venous Valve Disease Caused by Mutations in FOXC2 and GJC2
Part of Journal of Vascular Research, p. 62-62, 2017.
-
Human venous valve disease caused by mutations in FOXC2 and GJC2
Part of Journal of Experimental Medicine, p. 2437-2452, 2017.
DOI for Human venous valve disease caused by mutations in FOXC2 and GJC2 Download full text (pdf) of Human venous valve disease caused by mutations in FOXC2 and GJC2
-
Mechanisms underlying human venous valve disease caused by mutations in Foxc2 and connexin47
Part of British Journal of Surgery, p. 8-8, 2017.
DOI for Mechanisms underlying human venous valve disease caused by mutations in Foxc2 and connexin47
-
Vascular heterogeneity and specialization in development and disease
Part of Nature reviews. Molecular cell biology, p. 477-494, 2017.
DOI for Vascular heterogeneity and specialization in development and disease Download full text (pdf) of Vascular heterogeneity and specialization in development and disease
-
EPHB4 kinase-inactivating mutations cause autosomal dominant lymphatic-related hydrops fetalis
Part of Journal of Clinical Investigation, p. 3080-3088, 2016.
DOI for EPHB4 kinase-inactivating mutations cause autosomal dominant lymphatic-related hydrops fetalis Download full text (pdf) of EPHB4 kinase-inactivating mutations cause autosomal dominant lymphatic-related hydrops fetalis
-
Lymphatic System in Cardiovascular Medicine
Part of Circulation Research, p. 515-530, 2016.
-
Vegfr3-CreER (T2) mouse, a new genetic tool for targeting the lymphatic system
Part of Angiogenesis, p. 433-445, 2016.
DOI for Vegfr3-CreER (T2) mouse, a new genetic tool for targeting the lymphatic system Download full text (pdf) of Vegfr3-CreER (T2) mouse, a new genetic tool for targeting the lymphatic system
-
cKit Lineage Hemogenic Endothelium-Derived Cells Contribute to Mesenteric Lymphatic Vessels
Part of Cell reports, p. 1708-1721, 2015.
DOI for cKit Lineage Hemogenic Endothelium-Derived Cells Contribute to Mesenteric Lymphatic Vessels Download full text (pdf) of cKit Lineage Hemogenic Endothelium-Derived Cells Contribute to Mesenteric Lymphatic Vessels
-
FOXC2 and fluid shear stress stabilize postnatal lymphatic vasculature
Part of Journal of Clinical Investigation, p. 3861-3877, 2015.
DOI for FOXC2 and fluid shear stress stabilize postnatal lymphatic vasculature
-
Nonvenous Origin of Dermal Lymphatic Vasculature
Part of Circulation Research, p. 1649-1654, 2015.
-
Organ-Specific Origins of Lymphatic Vasculature
Part of Journal of Vascular Research, p. 18-19, 2015.
-
Therapeutic Insights to Lymphangiogenic Growth Factors
Part of Journal of Vascular Research, p. 19-19, 2015.
-
VEGFR3 does not sustain retinal angiogenesis without VEGFR2
Part of Proceedings of the National Academy of Sciences of the United States of America, p. 761-766, 2015.
DOI for VEGFR3 does not sustain retinal angiogenesis without VEGFR2
-
Lymphatic regulator PROX1 determines Schlemm's canal integrity and identity
Part of Journal of Clinical Investigation, p. 3960-3974, 2014.
DOI for Lymphatic regulator PROX1 determines Schlemm's canal integrity and identity
-
Lymphatic vascular morphogenesis
Part of Molecular Mechanisms of Angiogenesis, p. 25-44, 2014.
-
Regulation of Lymphatic Vasculature by Extracellular Matrix
Part of Developmental Aspects of the Lymphatic Vascular System, p. 55-65, 2014.
DOI for Regulation of Lymphatic Vasculature by Extracellular Matrix
-
The Schlemm's canal is a VEGF-C/VEGFR-3-responsive lymphatic-like vessel
Part of Journal of Clinical Investigation, p. 3975-3986, 2014.
DOI for The Schlemm's canal is a VEGF-C/VEGFR-3-responsive lymphatic-like vessel
-
Adrenomedullin haploinsufficiency predisposes to secondary lymphedema.
Part of Journal of Investigative Dermatology, 2013.
DOI for Adrenomedullin haploinsufficiency predisposes to secondary lymphedema.
-
Flow control in our vessels: vascular valves make sure there is no way back.
Part of Cellular and Molecular Life Sciences (CMLS), 2013.
DOI for Flow control in our vessels: vascular valves make sure there is no way back.
-
Regulation of lymphatic vascular morphogenesis: Implications for pathological (tumor) lymphangiogenesis
Part of Experimental Cell Research, p. 1618-1625, 2013.
-
Blood flow reprograms lymphatic vessels to blood vessels.
Part of Journal of Clinical Investigation, 2012.
DOI for Blood flow reprograms lymphatic vessels to blood vessels.
-
Mutations in KIF11 cause autosomal-dominant microcephaly variably associated with congenital lymphedema and chorioretinopathy.
Part of American Journal of Human Genetics, 2012.
-
Paladin (X99384) is expressed in the vasculature and shifts from endothelial to vascular smooth muscle cells during mouse development
Part of Developmental Dynamics, p. 770-786, 2012.
-
Genes regulating lymphangiogenesis control venous valve formation and maintenance in mice.
Part of Journal of Clinical Investigation, 2011.
DOI for Genes regulating lymphangiogenesis control venous valve formation and maintenance in mice.
-
EphB-ephrin-B2 interactions are required for thymus migration during organogenesis.
Part of Proceedings of the National Academy of Sciences of the United States of America, 2010.
DOI for EphB-ephrin-B2 interactions are required for thymus migration during organogenesis.
-
Lymphatic dysfunction, not aplasia, underlies Milroy disease.
Part of Microcirculation, 2010.
DOI for Lymphatic dysfunction, not aplasia, underlies Milroy disease.
-
Deletion of vascular endothelial growth factor C (VEGF-C) and VEGF-D is not equivalent to VEGF receptor 3 deletion in mouse embryos.
Part of Molecular and Cellular Biology, 2008.
-
Lymphangiogenesis in development and disease.
Part of Novartis Foundation symposium, 2007.
-
Lymphatic vasculature: a molecular perspective.
Part of Bioessays, 2007.
-
Molecular mechanisms of lymphatic vascular development.
Part of Cellular and Molecular Life Sciences (CMLS), 2007.
DOI for Molecular mechanisms of lymphatic vascular development.
-
Ligand-induced vascular endothelial growth factor receptor-3 (VEGFR-3) heterodimerization with VEGFR-2 in primary lymphatic endothelial cells regulates tyrosine phosphorylation sites
Part of Journal of Biological Chemistry, p. 40973-40979, 2003.
-
Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea.
Part of Proceedings of the National Academy of Sciences of the United States of America, 2002.
-
Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor.
Part of EMBO Journal, 2002.
-
Lymphatic endothelium: a new frontier of metastasis research.
Part of Nature Cell Biology, 2002.
DOI for Lymphatic endothelium: a new frontier of metastasis research.
-
[Lymphatic growth factors play a part in metastasis formation].
Part of Duodecim, 2002.
-
Molecular mechanisms of lymphangiogenesis.
Part of Cold Spring Harbor Symposia on Quantitative Biology, 2002.
-
Monoclonal antibodies to vascular endothelial growth factor-D block its interactions with both VEGF receptor-2 and VEGF receptor-3.
Part of European Journal of Biochemistry, 2000.
-
Differential binding of vascular endothelial growth factor B splice and proteolytic isoforms to neuropilin-1.
Part of Journal of Biological Chemistry, 1999.
-
Effect of inflammatory cytokines on the expression of the vascular endothelial growth factor-C.
Part of International journal of experimental pathology (Print), 1999.
-
Endothelial growth factor receptors in human fetal heart.
Part of Circulation, 1999.
-
Signaling via vascular endothelial growth factor receptors.
Part of Experimental Cell Research, 1999.
DOI for Signaling via vascular endothelial growth factor receptors.
-
Vascular endothelial growth factor receptor-3.
Part of Current Topics in Microbiology and Immunology, 1999.
-
Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1.
Part of Proceedings of the National Academy of Sciences of the United States of America, 1999.
-
Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4).
Part of Proceedings of the National Academy of Sciences of the United States of America, 1998.